Cargando…

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern threatens the efficacy of existing vaccines and therapeutic antibodies and underscores the need for additional antibody-based tools that potently neutralize variants by targeting multiple sites of the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hyeseon, Gonzales-Wartz, Kristina Kay, Huang, Deli, Yuan, Meng, Peterson, Mary, Liang, Janie, Beutler, Nathan, Torres, Jonathan L., Cong, Yu, Postnikova, Elena, Bangaru, Sandhya, Talana, Chloe Adrienna, Shi, Wei, Yang, Eun Sung, Zhang, Yi, Leung, Kwanyee, Wang, Lingshu, Peng, Linghang, Skinner, Jeff, Li, Shanping, Wu, Nicholas C., Liu, Hejun, Dacon, Cherrelle, Moyer, Thomas, Cohen, Melanie, Zhao, Ming, Lee, Frances Eun-Hyung, Weinberg, Rona S., Douagi, Iyadh, Gross, Robin, Schmaljohn, Connie, Pegu, Amarendra, Mascola, John R., Holbrook, Michael, Nemazee, David, Rogers, Thomas F., Ward, Andrew B., Wilson, Ian A., Crompton, Peter D., Tan, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651051/ https://www.ncbi.nlm.nih.gov/pubmed/34519517 http://dx.doi.org/10.1126/scitranslmed.abj5413

Ejemplares similares

Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
por: Cho, Hyeseon, et al.
Publicado: (2021)

Broadly neutralizing antibodies target the coronavirus fusion peptide
por: Dacon, Cherrelle, et al.
Publicado: (2022)

Broadly neutralizing antibodies target the coronavirus fusion peptide
por: Dacon, Cherrelle, et al.
Publicado: (2022)

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
por: Dacon, Cherrelle, et al.
Publicado: (2023)

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
por: Dacon, Cherrelle, et al.
Publicado: (2023)

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
por: Zhou, Tongqing, et al.
Publicado: (2022)

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
por: Shi, Wei, et al.
Publicado: (2022)

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
por: Shi, Wei, et al.
Publicado: (2022)

Suboptimal Immune Reconstitution in Vertically HIV Infected Children: A View on How HIV Replication and Timing of HAART Initiation Can Impact on T and B-cell Compartment
por: Cotugno, Nicola, et al.
Publicado: (2012)

Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
por: Liu, Cuiping, et al.
Publicado: (2023)

First identification of methicillin-resistant Staphylococcus pseudintermedius strains among coagulase-positive staphylococci isolated from dogs with otitis externa in Trinidad, West Indies
por: Dziva, Francis, et al.
Publicado: (2015)

β-hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells
por: Maldonado, Rylee, et al.
Publicado: (2021)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

The cell-type specific transcriptome in human adipose tissue and influence of obesity on adipocyte progenitors
por: Ehrlund, Anna, et al.
Publicado: (2017)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials
por: Huang, Yunda, et al.
Publicado: (2018)

Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
por: Wang, Lingshu, et al.
Publicado: (2021)

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
por: Wu, Nicholas C., et al.
Publicado: (2020)

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
por: Pegu, Amarendra, et al.
Publicado: (2021)

A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike Alone
por: Zhang, Baoshan, et al.
Publicado: (2020)

Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses
por: Lovelace, Sarah E., et al.
Publicado: (2022)

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
por: Wu, Nicholas C., et al.
Publicado: (2020)

A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone
por: Zhang, Baoshan, et al.
Publicado: (2020)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
por: Lima, Noemia S., et al.
Publicado: (2022)

PKconverter: R package to convert the pharmacokinetic parameters
por: Cho, Hyeseon, et al.
Publicado: (2019)

Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques
por: Wen, Jing, et al.
Publicado: (2021)

Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
por: Promsote, Wanwisa, et al.
Publicado: (2023)

Improvement of antibody functionality by structure-guided paratope engraftment
por: Liu, Qingbo, et al.
Publicado: (2019)

Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
por: Lima, Noemia S., et al.
Publicado: (2022)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
por: Dimitriou, Marios, et al.
Publicado: (2016)

An Online-Based Transition Care Program for Adolescents with Spina Bifida Using Intervention Mapping: A Protocol for Program Development
por: Choi, Eun Kyoung, et al.
Publicado: (2022)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
por: Chuang, Gwo-Yu, et al.
Publicado: (2021)

Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model
por: Plaza Reyes, Alvaro, et al.
Publicado: (2015)

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
por: Wang, Lingshu, et al.
Publicado: (2021)

A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention
por: Kwon, Young D., et al.
Publicado: (2021)

Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV
por: Vieira, Vinicius A., et al.
Publicado: (2022)

OA05-05. Impact of in vivo CD4 binding during HIV-1 Env trimer immunizations of rhesus macaques
por: Douagi, I, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_i80m9m02c2o898tl3tkgh98i88